Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Randomized, open-label, multicentre study to assess the efficacy and safety of the combination of low-dose rituximab and Iguratimod in patients with steroid-resistant/relapsed ITP.
Epistemonikos ID: 1ef472b1482b9496b36a8d957f43f87fe8501453
First added on: Jul 11, 2025